223721 Hepatitis B Vaccination Among High-Risk Adults in the United States

Sunday, November 7, 2010

Jacqueline Avery, MPH , National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Viral Hepatitis, Centers for Disease Control and Prevention (CDC), Atlanta, GA
Kathleen Koechlin, PhD, MPH, RN , HIV/STD/Adult Viral Hepatitis Prevention Program, Ohio Department of Health, Columbus, OH
Mila Verdugo, MPH , Immunization Program, Chicago Department of Public Health, Chicago, IL
Hope King, MSPH , National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Viral Hepatitis, Centers for Disease Control and Prevention (CDC), Atlanta, GA
  
Background: In 2006, the Centers for Disease Control and Prevention (CDC) published recommendations for vaccination of adults at risk for hepatitis B virus (HBV) infection. In October 2007, CDC launched the Adult Hepatitis B Vaccination Initiative. Utilizing Section 317 funds, hepatitis B-containing vaccines were purchased and provided at no cost to state and local health departments for distribution to venues targeting at-risk adults. Methods: To assess vaccination coverage of the three-dose series, data from two grantees, Chicago and Ohio, selected for their detailed data collection and variety of participating venues, were analyzed. We calculated the percentage of clients that received a first dose. Of those that received a first dose, we calculated the percentage that also received second and third doses. Results: From November 1, 2007 to December 31, 2009, a nationwide total of 542,546 hepatitis B-containing vaccine doses were administered at venues serving at-risk adults. Of these, a total of 47,829 vaccine doses were administered in Chicago and Ohio. In Chicago, 1,162 persons (74% of clients encountered) received a first dose; of these, 282 (24.3%) received a second dose and 20 (1.7%) received a third dose. In Ohio, 3,992 persons (44% of clients encountered) received a first dose; of these, 2,597 (28%) received a second dose and 2,596 (28%) received a third dose. Conclusions: Hepatitis B vaccination is the most effective measure in preventing HBV infection. When vaccine is supplied at no cost to clients, venues serving at-risk adults can immunize significant numbers against a vaccine preventable disease such as hepatitis B.

Learning Areas:
Epidemiology

Learning Objectives:
Demonstrate when vaccine is supplied at no cost to clients, venues serving at-risk adults can immunize significant numbers against a vaccine preventable disease such as hepatitis B.

Keywords: Hepatitis B, Disease Prevention

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am qualified to be an abstract author on the content I am responsible for because I oversee data analysis and provide technical assistance for the Adult Hepatitis B Vaccination Initiative at the CDC in the Division of Viral Hepatitis.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 2023.0: Vaccination and infectious disease epidemiology poster session